
Global Bioresorbable Ophthalmic Drug Delivery System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Bioresorbable Ophthalmic Drug Delivery System market size was valued at US$ 354 million in 2024 and is forecast to a readjusted size of USD 546 million by 2031 with a CAGR of 6.4% during review period.
Bioresorbable implants are inserted into the patient’s eye and safely absorbed by the body over time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Bioresorbable Ophthalmic Drug Delivery System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bioresorbable Ophthalmic Drug Delivery System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bioresorbable Ophthalmic Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bioresorbable Ophthalmic Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bioresorbable Ophthalmic Drug Delivery System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bioresorbable Ophthalmic Drug Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bioresorbable Ophthalmic Drug Delivery System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Allergan, Re-Vana Therapeutics, PolyActiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bioresorbable Ophthalmic Drug Delivery System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Anterior Drug Delivery Methods
Posterior Drug Delivery Methods
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Boehringer Ingelheim
Allergan
Re-Vana Therapeutics
PolyActiva
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bioresorbable Ophthalmic Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bioresorbable Ophthalmic Drug Delivery System, with price, sales quantity, revenue, and global market share of Bioresorbable Ophthalmic Drug Delivery System from 2020 to 2025.
Chapter 3, the Bioresorbable Ophthalmic Drug Delivery System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioresorbable Ophthalmic Drug Delivery System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bioresorbable Ophthalmic Drug Delivery System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bioresorbable Ophthalmic Drug Delivery System.
Chapter 14 and 15, to describe Bioresorbable Ophthalmic Drug Delivery System sales channel, distributors, customers, research findings and conclusion.
Bioresorbable implants are inserted into the patient’s eye and safely absorbed by the body over time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Bioresorbable Ophthalmic Drug Delivery System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bioresorbable Ophthalmic Drug Delivery System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bioresorbable Ophthalmic Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bioresorbable Ophthalmic Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Bioresorbable Ophthalmic Drug Delivery System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bioresorbable Ophthalmic Drug Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bioresorbable Ophthalmic Drug Delivery System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Allergan, Re-Vana Therapeutics, PolyActiva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bioresorbable Ophthalmic Drug Delivery System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Anterior Drug Delivery Methods
Posterior Drug Delivery Methods
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Boehringer Ingelheim
Allergan
Re-Vana Therapeutics
PolyActiva
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bioresorbable Ophthalmic Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bioresorbable Ophthalmic Drug Delivery System, with price, sales quantity, revenue, and global market share of Bioresorbable Ophthalmic Drug Delivery System from 2020 to 2025.
Chapter 3, the Bioresorbable Ophthalmic Drug Delivery System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioresorbable Ophthalmic Drug Delivery System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bioresorbable Ophthalmic Drug Delivery System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bioresorbable Ophthalmic Drug Delivery System.
Chapter 14 and 15, to describe Bioresorbable Ophthalmic Drug Delivery System sales channel, distributors, customers, research findings and conclusion.
Table of Contents
77 Pages
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Anterior Drug Delivery Methods
- 1.3.3 Posterior Drug Delivery Methods
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Others
- 1.5 Global Bioresorbable Ophthalmic Drug Delivery System Market Size & Forecast
- 1.5.1 Global Bioresorbable Ophthalmic Drug Delivery System Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Bioresorbable Ophthalmic Drug Delivery System Sales Quantity (2020-2031)
- 1.5.3 Global Bioresorbable Ophthalmic Drug Delivery System Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Boehringer Ingelheim
- 2.1.1 Boehringer Ingelheim Details
- 2.1.2 Boehringer Ingelheim Major Business
- 2.1.3 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Product and Services
- 2.1.4 Boehringer Ingelheim Bioresorbable Ophthalmic Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Boehringer Ingelheim Recent Developments/Updates
- 2.2 Allergan
- 2.2.1 Allergan Details
- 2.2.2 Allergan Major Business
- 2.2.3 Allergan Bioresorbable Ophthalmic Drug Delivery System Product and Services
- 2.2.4 Allergan Bioresorbable Ophthalmic Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Allergan Recent Developments/Updates
- 2.3 Re-Vana Therapeutics
- 2.3.1 Re-Vana Therapeutics Details
- 2.3.2 Re-Vana Therapeutics Major Business
- 2.3.3 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Product and Services
- 2.3.4 Re-Vana Therapeutics Bioresorbable Ophthalmic Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Re-Vana Therapeutics Recent Developments/Updates
- 2.4 PolyActiva
- 2.4.1 PolyActiva Details
- 2.4.2 PolyActiva Major Business
- 2.4.3 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Product and Services
- 2.4.4 PolyActiva Bioresorbable Ophthalmic Drug Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 PolyActiva Recent Developments/Updates
- 3 Competitive Environment: Bioresorbable Ophthalmic Drug Delivery System by Manufacturer
- 3.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Bioresorbable Ophthalmic Drug Delivery System Revenue by Manufacturer (2020-2025)
- 3.3 Global Bioresorbable Ophthalmic Drug Delivery System Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Bioresorbable Ophthalmic Drug Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Bioresorbable Ophthalmic Drug Delivery System Manufacturer Market Share in 2024
- 3.4.3 Top 6 Bioresorbable Ophthalmic Drug Delivery System Manufacturer Market Share in 2024
- 3.5 Bioresorbable Ophthalmic Drug Delivery System Market: Overall Company Footprint Analysis
- 3.5.1 Bioresorbable Ophthalmic Drug Delivery System Market: Region Footprint
- 3.5.2 Bioresorbable Ophthalmic Drug Delivery System Market: Company Product Type Footprint
- 3.5.3 Bioresorbable Ophthalmic Drug Delivery System Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Bioresorbable Ophthalmic Drug Delivery System Market Size by Region
- 4.1.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Region (2020-2031)
- 4.1.2 Global Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Region (2020-2031)
- 4.1.3 Global Bioresorbable Ophthalmic Drug Delivery System Average Price by Region (2020-2031)
- 4.2 North America Bioresorbable Ophthalmic Drug Delivery System Consumption Value (2020-2031)
- 4.3 Europe Bioresorbable Ophthalmic Drug Delivery System Consumption Value (2020-2031)
- 4.4 Asia-Pacific Bioresorbable Ophthalmic Drug Delivery System Consumption Value (2020-2031)
- 4.5 South America Bioresorbable Ophthalmic Drug Delivery System Consumption Value (2020-2031)
- 4.6 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Type (2020-2031)
- 5.2 Global Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Type (2020-2031)
- 5.3 Global Bioresorbable Ophthalmic Drug Delivery System Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Application (2020-2031)
- 6.2 Global Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Application (2020-2031)
- 6.3 Global Bioresorbable Ophthalmic Drug Delivery System Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Type (2020-2031)
- 7.2 North America Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Application (2020-2031)
- 7.3 North America Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
- 7.3.1 North America Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Country (2020-2031)
- 7.3.2 North America Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Type (2020-2031)
- 8.2 Europe Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Application (2020-2031)
- 8.3 Europe Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
- 8.3.1 Europe Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Bioresorbable Ophthalmic Drug Delivery System Market Size by Region
- 9.3.1 Asia-Pacific Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Type (2020-2031)
- 10.2 South America Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Application (2020-2031)
- 10.3 South America Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
- 10.3.1 South America Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Country (2020-2031)
- 10.3.2 South America Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Market Size by Country
- 11.3.1 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Bioresorbable Ophthalmic Drug Delivery System Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Bioresorbable Ophthalmic Drug Delivery System Market Drivers
- 12.2 Bioresorbable Ophthalmic Drug Delivery System Market Restraints
- 12.3 Bioresorbable Ophthalmic Drug Delivery System Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Bioresorbable Ophthalmic Drug Delivery System and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Bioresorbable Ophthalmic Drug Delivery System
- 13.3 Bioresorbable Ophthalmic Drug Delivery System Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Bioresorbable Ophthalmic Drug Delivery System Typical Distributors
- 14.3 Bioresorbable Ophthalmic Drug Delivery System Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.